Skip to main content

Vistagen Therapeutics, Inc.

VTGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001411685

No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Vistagen Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of VTGN: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders105106+1
Shares131.4M138.2M+6.73M (+5.1%)
Value$360.2M$269.2M−$91.0M (−25.3%)

New holders (12)

Institutions that held Vistagen Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to VTGN in Q4 2021
InstitutionSharesValue% of portfolio
Logos Global Management LP2,000,000$3.90M0.40%
Rock Creek Group, LP161,589$263.0K0.04%
Ergoteles LLC102,847$201.0K0.01%
HRT Financial LP58,045$113.0K0.00%
Virtu Financial LLC20,511$40.0K0.00%
Eagle Asset Management Inc14,723$30.0K0.00%
Bank of Montreal14,800$30.0K0.00%
CWM, LLC13,500$26.0K0.00%
ExodusPoint Capital Management, LP12,000$23.0K0.00%
Drive Wealth Management, LLC10,000$20.0K0.02%
Aquatic Capital Management LLC5,400$11.0K0.02%
Confluence Wealth Services, Inc.1,700$3.00K0.00%

Sold out (11)

Institutions that held Vistagen Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of VTGN in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
EAM Investors, LLC842,545$2.31M
Victory Capital Management Inc795,720$2.18M
EAM Global Investors LLC634,743$1.74M
Exencial Wealth Advisors, LLC98,731$271.0K
LPL Financial LLC33,434$92.0K
Gsa Capital Partners LLP31,984$88.0K
Cubist Systematic Strategies, LLC14,800$41.0K
Centaurus Financial, Inc.10,115$28.0K
Koshinski Asset Management, Inc.3,600$9.86K
Global Retirement Partners, LLC2,000$5.00K
Gerber Kawasaki Wealth & Investment Management144$0